56
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2902443
Angimmune develops immunotherapies for cancer and autoimmune diseases, focusing on anti-T cell therapy.
About the Company
Angimmune is a biotechnology company focused on developing immunotherapies for the treatment of cancer and autoimmune diseases. Utilizing a unique anti-T cell therapy technology, Angimmune designs highly potent immunotoxin molecules. The company's therapeutic approach targets T cell blood cancers, T cell driven autoimmune diseases, and aims to
advance immuno-oncology treatments. With a pipeline that includes four clinical trials, Angimmune's research addresses neoplasms and immune system diseases. Founded by experts from the National Institute of Health, the company is dedicated to leveraging its expertise in the field to develop innovative treatments.
